CVE-2022-1518 3.2.2 IMPROPER LIMITATION OF A PATHNAME TO A RESTRICTED DIRECTORY ('PATH TRAVERSAL') CWE-22
A path traversal vulnerability in Illumina sequencing instruments allows attackers to upload files outside the intended directory structure.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2022-1518?
CVE-2022-1518 is a critical path traversal vulnerability in Illumina MiSeq Dx, published on 24 Jun 2022. An attacker can exploit it over the internet without logging in, with no action from the victim.
Official description
LRM contains a directory traversal vulnerability that can allow a malicious actor to upload outside the intended directory structure.
Weakness: CWE-22
Which versions are affected by CVE-2022-1518?
It affects 1 product.
Products include Illumina Local Run Manager.
How do I fix CVE-2022-1518?
No fix has been published for CVE-2022-1518 yet. Limit exposure of the affected software until one is available.
Upgrade, and resolve every user-supplied path against an allowed base folder before opening it. More about Path traversal.
Is CVE-2022-1518 being exploited?
There is no known exploitation of CVE-2022-1518 in the wild and no public exploit code.
Other vulnerabilities in Illumina MiSeq Dx
Sources
Also known as GHSA-gf32-9r48-vxjm.